Projects per year
Fingerprint Dive into the research topics where Christopher J. Destache is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Nanoparticles
Medicine & Life Sciences
HIV-1
Medicine & Life Sciences
Pharmacokinetics
Medicine & Life Sciences
Rilpivirine
Medicine & Life Sciences
HIV
Medicine & Life Sciences
Tenofovir
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2018
- 3 Finished
Long-acting antiretroviral nanoparticles for HIV prophylaxis
2/4/15 → 1/31/18
Project: Research project
Nanoparticles
HIV
Rilpivirine
Tenofovir
Drug Combinations
Once Monthly Antiretroviral Nanoparticles for HIV-1 Treatment
6/15/11 → 5/31/13
Project: Research project
Nanoparticles
HIV-1
Therapeutics
Macaca
Macaca nemestrina
Micelles
Nanoparticles
HIV-1
Pharmacology
efavirenz
Research Output 1985 2019
A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study
Mandal, S., Prathipati, P. K., Belshan, M. A. & Destache, C. J., Jul 1 2019, In : Antiviral Research. 167, p. 83-88 6 p.Research output: Contribution to journal › Article
Drug Delivery Systems
HIV Infections
HIV-1
Integrases
Emulsions
A review of CCR5 antibodies against HIV: current and future aspects
Prathipati, P. K., Mandal, S. & Destache, C. J., Feb 1 2019, In : Therapeutic Delivery. 10, 2, p. 107-112 6 p.Research output: Contribution to journal › Article
HIV Antibodies
HIV
Viruses
Antibodies
Virus Diseases
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experience
Destache, C. J., Guervil, D. J. & Kaye, K. S., Jan 1 2019, In : International Journal of Antimicrobial Agents.Research output: Contribution to journal › Article
Open Access
Endocarditis
Therapeutics
Methicillin-Resistant Staphylococcus aureus
Methicillin
PPI-0903
Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model (Pharmaceutical Research, (2017), 34, 12, (2749-2755), 10.1007/s11095-017-2255-7)
Prathipati, P. K., Mandal, S., Pon, G., Vivekanandan, R. & Destache, C. J., Jul 1 2019, In : Pharmaceutical Research. 36, 7, 108.Research output: Contribution to journal › Comment/debate
Open Access
Pharmacokinetics
Tissue Distribution
Nanoparticles
Tissue
Pharmaceutical Preparations
Corrigendum to “Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission” [Journal of Controlled Release 294 (2019)216–225](S0168365918307302)(10.1016/j.jconrel.2018.12.027)
Mandal, S., Kang, G., Prathipati, P. K., Zhou, Y., Fan, W., Li, Q. & Destache, C. J., Jun 28 2019, In : Journal of Controlled Release. 304, 1 p.Research output: Contribution to journal › Comment/debate
Drug Combinations
HIV-1
Pharmacokinetics
Drug Interactions
Pharmaceutical Preparations